Literature DB >> 35133501

Osteocondritis dissecans lesions of the knee restored by bone marrow aspirate concentrate. Clinical and imaging results in 18 patients.

Matteo Baldassarri1, Roberto Buda2, Luca Perazzo3,4, Diego Ghinelli1, Ricciardello Sarino5, Brunella Grigolo6, Cesare Faldini7.   

Abstract

BACKGROUND: Osteochondritis dissecans (OCD) is a common cartilage disorder that specifically affects the knees of skeletally immature and young adult patients. There have been a few treatments that have been proposed: fixation of the fragment, drilling, microfractures. The aim of this study was to analyze retrospectively clinical and imaging results obtained by treating it with one-step bone marrow-derived cells Transplantation (BMDCT) technique.
METHODS: From 2007 to 2014, 18 patients (mean-age 19.1 ± 5.0 years) affected by OCD were treated with one-step BMDC transplantation. In our observational study, clinical evaluation was performed at a scheduled follow-up through IKDC, Tegner, KOOS and EQ-VAS. X-rays and MRI were conducted preoperatively and at 12 months. At final follow-up, MRI MOCART Score was evaluated.
RESULTS: IKDC and KOOS clinical scores showed a progressive increase. Tegner Score at final follow-up (5.3 ± 2.7) was significantly lower compared to the pre-injury level (6.5 ± 2.1); however, these results showed a statistically significant improvement that remained over time. EQ-VAS showed a significant improvement in every follow-up measure. MRI Mocart Score showed a complete or almost complete filling of the lesion in 13 patients.
CONCLUSIONS: "One-step" technique allows articular surface restoration with viable physiologic osteochondral tissue with a high clinical efficacy and imaging results. The number of cases is still limited, and further studies with larger sample sizes and greater follow-up evaluations are required to confirm our results. Nevertheless, we believe that BMDCT may represent a suitable option to treat OCD lesion in young adults.
© 2022. The Author(s).

Entities:  

Keywords:  Bone marrow-derived cell transplantation (BMDCT); Cartilage; Knee; Osteochondritis dissecans (OCD)

Year:  2022        PMID: 35133501     DOI: 10.1007/s00590-022-03214-1

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  7 in total

Review 1.  Management of osteochondritis dissecans of the knee: current concepts review.

Authors:  Mininder S Kocher; Rachael Tucker; Theodore J Ganley; John M Flynn
Journal:  Am J Sports Med       Date:  2006-07       Impact factor: 6.202

2.  The classic: On loose bodies in the joint. 1887.

Authors:  Franz König
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

3.  One-step arthroscopic technique for the treatment of osteochondral lesions of the knee with bone-marrow-derived cells: three years results.

Authors:  Roberto Buda; Francesca Vannini; Marco Cavallo; Matteo Baldassarri; Deianira Luciani; Antonio Mazzotti; Camilla Pungetti; Alessandra Olivieri; Sandro Giannini
Journal:  Musculoskelet Surg       Date:  2013-02-19

4.  Minimum ten-year results of a prospective randomised study of autologous chondrocyte implantation versus mosaicplasty for symptomatic articular cartilage lesions of the knee.

Authors:  G Bentley; L C Biant; S Vijayan; S Macmull; J A Skinner; R W J Carrington
Journal:  J Bone Joint Surg Br       Date:  2012-04

5.  Juvenile osteochondritis dissecans.

Authors:  G L Glancy
Journal:  Am J Knee Surg       Date:  1999

6.  Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model.

Authors:  Fanglong Song; Jilei Tang; Rui Geng; Hansheng Hu; Chunhui Zhu; Weiding Cui; Weimin Fan
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 7.  Why are MSCs therapeutic? New data: new insight.

Authors:  A I Caplan
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.